- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Windlas Biotech Limited has announced a board meeting focusing on the financial results for the quarter and half-year ended September 30, 2024. The agenda will cover the review and approval of the company's unaudited standalone and consolidated financial results. This meeting's outcomes will provide insights into the company's performance and strategic direction going forward. Investors should keep an eye on this meeting to assess potential impacts on stock performance.